PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.77%
Revenue growth above 1.5x 3088.T's 0.37%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
2.33%
Positive gross profit growth while 3088.T is negative. John Neff would see a clear operational edge over the competitor.
7.47%
Positive EBIT growth while 3088.T is negative. John Neff might see a substantial edge in operational management.
11.60%
Operating income growth above 1.5x 3088.T's 0.52%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
7.06%
Positive net income growth while 3088.T is negative. John Neff might see a big relative performance advantage.
7.10%
Positive EPS growth while 3088.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
7.10%
Positive diluted EPS growth while 3088.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.00%
Share change of 0.00% while 3088.T is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.00%
Diluted share change of 0.00% while 3088.T is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
-113.60%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-470.38%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
30.78%
10Y revenue/share CAGR above 1.5x 3088.T's 6.75%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
30.78%
5Y revenue/share CAGR above 1.5x 3088.T's 6.75%. David Dodd would look for consistent product or market expansions fueling outperformance.
30.78%
3Y revenue/share CAGR above 1.5x 3088.T's 6.75%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
73.51%
Positive long-term OCF/share growth while 3088.T is negative. John Neff would see a structural advantage in sustained cash generation.
73.51%
Positive OCF/share growth while 3088.T is negative. John Neff might see a comparative advantage in operational cash viability.
73.51%
Positive 3Y OCF/share CAGR while 3088.T is negative. John Neff might see a big short-term edge in operational efficiency.
96.43%
Positive 10Y CAGR while 3088.T is negative. John Neff might see a substantial advantage in bottom-line trajectory.
96.43%
Positive 5Y CAGR while 3088.T is negative. John Neff might view this as a strong mid-term relative advantage.
96.43%
Positive short-term CAGR while 3088.T is negative. John Neff would see a clear advantage in near-term profit trajectory.
48.59%
10Y equity/share CAGR above 1.5x 3088.T's 11.68%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
48.59%
5Y equity/share CAGR above 1.5x 3088.T's 11.68%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
48.59%
3Y equity/share CAGR above 1.5x 3088.T's 11.68%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.84%
Inventory is declining while 3088.T stands at 4.96%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.83%
Negative asset growth while 3088.T invests at 3.34%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
4.96%
BV/share growth above 1.5x 3088.T's 1.64%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-10.36%
We’re deleveraging while 3088.T stands at 11.18%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.